Cita APA

Cornely, O. A., Watt, M., McCrea, C., Goldenberg, S. D., & De Nigris, E. (2018). Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): Analysis of cost-effectiveness. J Antimicrob Chemother.

Citación estilo Chicago

Cornely, Oliver A., Maureen Watt, Charles McCrea, Simon D. Goldenberg, y Enrico De Nigris. "Extended-pulsed Fidaxomicin Versus Vancomycin for Clostridium Difficile Infection in Patients Aged ≥60 Years (EXTEND): Analysis of Cost-effectiveness." J Antimicrob Chemother 2018.

Cita MLA

Cornely, Oliver A., et al. "Extended-pulsed Fidaxomicin Versus Vancomycin for Clostridium Difficile Infection in Patients Aged ≥60 Years (EXTEND): Analysis of Cost-effectiveness." J Antimicrob Chemother 2018.